Mark Grossetete
Neurology · Santa Rosa, NMNPI 1447592498
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,840 of the $4,119 with a category attached, or 69.0%. 11 manufacturers reported payments, led by Stryker at 26.9% of the total.
Across 125 payments — averaging $32.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Nevro Corp.$783
- Nalu Medical, Inc.$569
- Abbott$545
- Globus Medical$506
- Medtronic$293
- plus $314 from 5 others
What the payments were for
- Travel & lodging$1,27931%
- Food & beverage$2,84069%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 6 | $1,108 |
| Nevro Corp. | 37 | $783 |
| Nalu Medical, Inc. | 8 | $569 |
| Abbott | 24 | $545 |
| Globus Medical | 20 | $506 |
| Medtronic | 16 | $293 |
| AbbVie | 8 | $185 |
| Vertex | 2 | $45 |
| Boston Scientific | 2 | $43 |
| Si-bone, Inc. | 1 | $26 |
| Relievant Medsystems, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,119 in reported general payments places this provider in the 75th percentile of 91 neurology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 37 | $4,924 |
| Naloxone Hcl | 41 | $2,887 |
| Oxycodone Hcl | 109 | $2,473 |
| Gabapentin | 83 | $1,378 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 68 | $1,345 |
| Pregabalin | 58 | $922 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $817 |
| Tramadol Hcl | 26 | $740 |
| Tizanidine Hcl | 23 | $294 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $278 |
| Ibuprofen | 12 | $129 |
| Meloxicam | 14 | $81 |
| Cyclobenzaprine Hcl | 14 | $74 |
Paid to pharmacies, not to this prescriber.
Other neurology in Santa Rosa
- Elaine EdmondsAlbuquerque$610K
- Kader AbdelerahmanAlbuquerque$607K
- Weiwei DaiRio Rancho$367K
- Timothy OwnbeyAlbuquerque$90K
- Gerson Suarez CedenoAlbuquerque$44K
- Corey FordAlbuquerque$27K
- Diksha MohantyAlbuquerque$20K
- Douglas BarrettAlbuquerque$19K
- Vanessa Licona SanjuanAlbuquerque$16K
- Daniel ShibuyaAlbuquerque$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.